Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis

Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis

Objective: The purpose of this meta-analysis is to investigate the effectiveness of the prognostic roles of blood inflammatory markers in hepatocellular carcinoma (HCC) patients receiving sorafenib.Methods: We carried out a comprehensive literature search in four databases. Study endpoints, hazard r...

Full description

Bibliographic Details
Main Authors: Lixing Liu, Yang Gong, Qinglin Zhang, Panpan Cai, Li Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Oncology
Subjects:
neutrophil-to-lymphocyte ratio
platelet-to-lymphocyte ratio
hepatocellular carcinoma
sorafenib
inflammatory biomarkers
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01557/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01557/full

Similar Items